Fentonium bromide

Fentonium bromide
Clinical data
ATC code	A03BB04 (WHO) ;
Pharmacokinetic data
Bioavailability	1
Identifiers
	IUPAC name [8-Methyl-8-[2-oxo-2-(4-phenylphenyl)ethyl]-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate bromide;
CAS Number	5868-06-4 ;
PubChem CID	71534;
DrugBank	DB08978 ;
UNII	XS152O7VCZ;
ECHA InfoCard	100.025.018
Chemical and physical data
Formula	C31H34BrNO4
Molar mass	564.520 g·mol−1
	(what is this?) (verify)

Fentonium bromide (INN) is an anticholinergic and antispasmodic atropine derivative.^[1] In the US its patent number is 3,356,682.^[2] It is sold by Sanofi-Aventis and Zambon.^[3]

References

^ Milne GW (2002). "Fentonium bromide". Drugs: Synonyms and Properties (2nd ed.). Aldershot, Hampshire, England: Ashgate. p. 2785. ISBN 978-0-566-08491-1.
^ "Fentonium". DrugBank. 17 August 2016. Retrieved 19 December 2016.
^ "Ulcesium (fentonium bromide) drug & pharmaceuticals. Ulcesium available forms, doses, prices". sdrugs.com. Retrieved 19 December 2016.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.